SC 13G: CG Oncology, Inc.

AI Summary

SC 13G filing by CG Oncology, Inc..

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.0001 — Inc. (Name of Issuer) Common stock, $0.0001 par value per share (Title of Class o

Filing Documents

• d840327dsc13g.htm (SC 13G) — 180KB
• d840327dex991.htm (EX-99.1) — 13KB
• 0001193125-24-182242.txt ( ) — 195KB

From the Filing

SC 13G 1 d840327dsc13g.htm SC 13G SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.)* CG Oncology, Inc. (Name of Issuer) Common stock, $0.0001 par value per share (Title of Class of Securities) 156944100 (CUSIP Number) June 30, 2024** (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. ** We are early adopting the revised filing deadline under the new Rule 13d-1(d) which went effective on February 5, 2024 and will require compliance starting on September 30, 2024. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 156944100 1. Names of Reporting Persons Unique Diamond Investments Limited 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)(b) 3. SEC Use Only 4. Citizenship or Place of Organization British Virgin Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. Sole Voting Power 1,011,192 (1) 6. Shared Voting Power 0 7. Sole Dispositive Power 1,011,192 (1) 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,011,192 (1) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 1.5% (2) 12. Type of Reporting Person (See Instructions) CO (1) Consists of 1,011,192 shares of the Issuers Common Stock (as defined in item 2(d)) held directly by Unique Diamond Investments Limited. (2) This calculation is based on 66,640,150 shares of Common Stock outstanding as of May 6, 2024, as reported in the Issuers Quarterly Report on Form 10-Q filed with the SEC on May 9, 2024. CUSIP No. 156944100 1. Names of Reporting Persons ORI Healthcare Fund, L.P. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)(b) 3. SEC Use Only 4. Citizenship or Place of Organization Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. Sole Voting Power 1,011,192 (1) 6. Shared Voting Power 0 7. Sole Dispositive Power 1,011,192 (1) 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,011,192 (1) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 1.5% (2) 12. Type of Reporting Person (See Instructions) PN (1) Represents 1,011,192 shares of the Issuers Common Stock held directly by Unique Diamond Investments Limited. Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. (2) This calculation is based on 66,640,150 shares of Common Stock outstanding as of May 6, 2024, as reported in the Issuers Quarterly Report on Form 10-Q filed with the SEC on May 9, 2024. CUSIP No. 156944100 1. Names of Reporting Persons ORI Capital Inc. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)(b) 3. SEC Use Only 4. Citizenship or Place of Organization Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. Sole Voting Power 1,011,192 (1) 6. Shared Voting Power 0 7. Sole Dispositive Power 1,011,192 (1) 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,011,192 (1) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) 11. Percent of Class Represented by Amount in Row (9) 1.5% (2) 12. Type of Reporting Person (See Instructions) CO (1) Represents 1,011,192 shares of the Issuers Common Stock held directly by Unique Diamond Investments Limited. Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P. and may be deemed to have voting, investment and dispositive power with respect to these securities. (2) This calculation is based on 66,640,150 shares of Common Stock outstanding as of May 6, 2024, as reported in the Issuers Quarterly Report on Form 10-Q filed with the SEC on May 9, 2024. CUSIP No. 156944100 1. Names of Reporting Persons ORI

View Full Filing

View this SC 13G filing on SEC EDGAR